26.12.2012 Views

IARC MONOGRAPHS ON THE EVALUATION OF CARCINOGENIC ...

IARC MONOGRAPHS ON THE EVALUATION OF CARCINOGENIC ...

IARC MONOGRAPHS ON THE EVALUATION OF CARCINOGENIC ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

410<br />

had deficient glucose-6-phosphate dehydrogenase activity in the erythrocytes (Valaes<br />

et al., 1963).<br />

Two case reports of haemolytic anaemia in newborn infants secondary to maternal<br />

ingestion of mothballs or inhalation exposure to naphthalene have been reported. This<br />

indicates that naphthalene and/or its metabolites can pass the placenta (Anziulewicz<br />

et al., 1959; Athanasiou et al., 1997). [The Working Group noted that the exposure<br />

concentration of naphthalene was not reported.]<br />

4.3.2 Experimental systems<br />

<strong>IARC</strong> <strong>M<strong>ON</strong>OGRAPHS</strong> VOLUME 82<br />

(a) Developmental toxicity studies in vivo<br />

In CD-1 mice given 300 mg/kg bw naphthalene per day by gavage on gestation days<br />

7–14, maternal lethality was increased, maternal weight gain was decreased and the<br />

average number of live offspring per litter was decreased. There was no concomitant<br />

increase in the number of dead pups, suggesting that the smaller litter size was due to<br />

early embryonic resorption (Plasterer et al., 1985).<br />

In a teratogenicity study in New Zealand white rabbits treated by gavage with up to<br />

120 mg/kg bw on gestation days 6–19, no signs of developmental or maternal toxicity<br />

were found (Navarro et al., 1992).<br />

When Sprague-Dawley rats were given intraperitoneal injections of 395 mg/kg bw<br />

naphthalene per day on days 1–15 of gestation, no evidence of maternal toxicity or<br />

developmental toxicity was found (Hardin et al., 1981).<br />

Some indications of developmental toxicity were observed when Sprague-Dawley<br />

rats were given up to 450 mg/kg bw naphthalene per day by gavage on gestational days<br />

6–15. Maternal weight gain was reduced in the groups that received 150 and 450 mg/kg<br />

bw per day. There was a significant trend towards decreased fetal body weight and<br />

towards an increased percentage of adversely affected implants per litter (i.e., non-live or<br />

malformed). An increased incidence of visceral malformations was reported, especially<br />

enlarged ventricles of the brain. The percentage of malformed fetuses per litter seen in<br />

the 450-mg/kg bw group was 2.5 times greater than in controls, but this difference was<br />

not significant (Navarro et al., 1991).<br />

(b) Developmental toxicity studies in vitro<br />

Preimplantation embryos of ICR mice exposed in vivo by intraperitoneal injection of<br />

the mother with 14 or 56 mg/kg bw naphthalene on gestational day 2 were collected on<br />

gestational day 3.5. Their subsequent in-vitro growth was markedly reduced during 72 h<br />

of culture. The viability and implantation capacity were also significantly inhibited (Iyer<br />

et al., 1990).<br />

In a study of the role of biotransformation on the rodent in-vitro preimplantation<br />

embryotoxicity of naphthalene, no toxic effects were observed in the absence of a rat S9<br />

activation system in the culture medium. In the presence of the S9 system, naphthalene<br />

caused concentration-dependent embryolethality (approximate LC 50, 0.18 mM). This

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!